Objectives: To develop prediction models for the individual-level impacts of cardiovascular events on UK healthcare costs. Methods: In the UK Biobank, people 40-70 years old, recruited in 2006-2010, were followed in linked primary (N=192 983 individuals) and hospital care (N=501 807 individuals) datasets. Primary and hospital care costs’ (2020 UK£) regression models of annual costs associated with individual characteristics and experiences of myocardial infarction (MI), stroke, coronary revascularization, incident diabetes and cancer, and vascular and nonvascular death are reported. Results: For both people without and with previous CVD, primary care costs were modelled using onepart generalised linear models (GLMs) with identity link and...
Abstract Background and purpose Cardiovascular disease (CVD) risk of individuals depends on their s...
Background: Prediction models for cardiovascular events and cardiovascular death in patients with es...
Objectives: This is the second of the two papers introducing a cardiovascular disease (CVD) policy m...
OBJECTIVES: To characterise the costs to the UK National Health Service of cardiovascular (CV) event...
Background: In this study, we developed cost prediction equations that facilitate estimation of the ...
Background To investigate the ability of multiple cardiovascular disease (CVD) markers to predict fu...
To investigate the ability of multiple cardiovascular disease (CVD) markers to predict future health...
This new research report demonstrates the scale of the burden of cardiovascular disease (CVD) - show...
Background: We project incidence and prevalence of stroke in the UK and associated costs to society ...
Background: there are around 100,000 new stroke cases and over a million people living with its cons...
BackgroundThere is uncertainty around the health impact and economic costs of the recent slowing of ...
Aims: Robust cost estimates are required to inform economic analysis of diabetes treatments. We esti...
BACKGROUND:Aiming to contribute to prevention of cardiovascular disease (CVD), the National Health S...
BACKGROUND: Prediction models for cardiovascular events and cardiovascular death in patients with es...
Evidence on the cost-effectiveness of healthcare interventions is increasingly required by decision-...
Abstract Background and purpose Cardiovascular disease (CVD) risk of individuals depends on their s...
Background: Prediction models for cardiovascular events and cardiovascular death in patients with es...
Objectives: This is the second of the two papers introducing a cardiovascular disease (CVD) policy m...
OBJECTIVES: To characterise the costs to the UK National Health Service of cardiovascular (CV) event...
Background: In this study, we developed cost prediction equations that facilitate estimation of the ...
Background To investigate the ability of multiple cardiovascular disease (CVD) markers to predict fu...
To investigate the ability of multiple cardiovascular disease (CVD) markers to predict future health...
This new research report demonstrates the scale of the burden of cardiovascular disease (CVD) - show...
Background: We project incidence and prevalence of stroke in the UK and associated costs to society ...
Background: there are around 100,000 new stroke cases and over a million people living with its cons...
BackgroundThere is uncertainty around the health impact and economic costs of the recent slowing of ...
Aims: Robust cost estimates are required to inform economic analysis of diabetes treatments. We esti...
BACKGROUND:Aiming to contribute to prevention of cardiovascular disease (CVD), the National Health S...
BACKGROUND: Prediction models for cardiovascular events and cardiovascular death in patients with es...
Evidence on the cost-effectiveness of healthcare interventions is increasingly required by decision-...
Abstract Background and purpose Cardiovascular disease (CVD) risk of individuals depends on their s...
Background: Prediction models for cardiovascular events and cardiovascular death in patients with es...
Objectives: This is the second of the two papers introducing a cardiovascular disease (CVD) policy m...